Q2 EPS Estimates for Henry Schein Raised by Leerink Partnrs

Henry Schein, Inc. (NASDAQ:HSIC - Free Report) - Equities researchers at Leerink Partnrs boosted their Q2 2025 EPS estimates for shares of Henry Schein in a research report issued to clients and investors on Monday, July 14th. Leerink Partnrs analyst M. Cherny now anticipates that the company will earn $1.22 per share for the quarter, up from their prior estimate of $1.16. The consensus estimate for Henry Schein's current full-year earnings is $4.74 per share. Leerink Partnrs also issued estimates for Henry Schein's Q4 2025 earnings at $1.22 EPS, FY2025 earnings at $4.83 EPS and FY2027 earnings at $5.72 EPS.

Several other analysts have also recently issued reports on the stock. Baird R W cut shares of Henry Schein from a "strong-buy" rating to a "hold" rating in a report on Monday. Barrington Research cut their price target on shares of Henry Schein from $90.00 to $86.00 and set an "outperform" rating for the company in a report on Tuesday, May 6th. Piper Sandler reduced their price objective on shares of Henry Schein from $83.00 to $77.00 and set an "overweight" rating for the company in a research note on Wednesday, April 30th. Evercore ISI upped their target price on Henry Schein from $72.00 to $78.00 and gave the company an "in-line" rating in a report on Wednesday, July 9th. Finally, Wall Street Zen downgraded Henry Schein from a "buy" rating to a "hold" rating in a report on Thursday, April 17th. Eight equities research analysts have rated the stock with a hold rating and four have issued a buy rating to the company. According to data from MarketBeat.com, Henry Schein presently has an average rating of "Hold" and a consensus target price of $78.36.

Henry Schein Trading Down 0.6%

Henry Schein stock traded down $0.40 during trading on Wednesday, reaching $69.10. The company had a trading volume of 1,177,871 shares, compared to its average volume of 1,741,855. The firm has a market capitalization of $8.41 billion, a price-to-earnings ratio of 21.59, a PEG ratio of 2.25 and a beta of 0.87. The company has a debt-to-equity ratio of 0.50, a quick ratio of 0.75 and a current ratio of 1.38. Henry Schein has a 12-month low of $60.56 and a 12-month high of $82.49. The stock's 50 day moving average price is $71.81 and its two-hundred day moving average price is $71.32.

Henry Schein (NASDAQ:HSIC - Get Free Report) last posted its earnings results on Monday, May 5th. The company reported $1.15 earnings per share for the quarter, beating the consensus estimate of $1.11 by $0.04. The firm had revenue of $3.17 billion during the quarter, compared to the consensus estimate of $3.24 billion. Henry Schein had a net margin of 3.21% and a return on equity of 14.87%. The firm's revenue for the quarter was down .1% on a year-over-year basis. During the same period last year, the firm posted $1.10 EPS.

Hedge Funds Weigh In On Henry Schein

Several institutional investors have recently modified their holdings of HSIC. Proficio Capital Partners LLC bought a new position in shares of Henry Schein during the 4th quarter valued at about $943,000. HighTower Advisors LLC lifted its stake in Henry Schein by 242.9% in the 4th quarter. HighTower Advisors LLC now owns 43,347 shares of the company's stock valued at $3,000,000 after acquiring an additional 30,706 shares in the last quarter. Sequoia Financial Advisors LLC lifted its stake in Henry Schein by 7.2% in the 4th quarter. Sequoia Financial Advisors LLC now owns 6,109 shares of the company's stock valued at $423,000 after acquiring an additional 412 shares in the last quarter. Thrivent Financial for Lutherans lifted its stake in Henry Schein by 10.8% in the 4th quarter. Thrivent Financial for Lutherans now owns 116,843 shares of the company's stock valued at $8,085,000 after acquiring an additional 11,428 shares in the last quarter. Finally, Xponance Inc. lifted its stake in Henry Schein by 1.7% in the 4th quarter. Xponance Inc. now owns 19,240 shares of the company's stock valued at $1,331,000 after acquiring an additional 315 shares in the last quarter. Institutional investors own 96.62% of the company's stock.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.